Screen testing cardiovascular prevention in asymptomatic diabetic patients

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Health Economics

Background:

• Asymptomatic diabetic patients are at high risk for subclinical atherosclerotic disease.
• Myocardial perfusion scintigraphy is proposed for routine screening in this population.
• Current guidelines do not universally recommend routine screening for all asymptomatic diabetics.

Purpose of the Study:

• To compare the cost-effectiveness of a conditional test-treatment strategy versus an unconditional treatment strategy for asymptomatic diabetic patients.
• To evaluate the national economic and clinical impact of routine myocardial perfusion scintigraphy screening.

Main Methods:

• Decision-analytic modeling was used to compare two strategies: conditional (scintigraphy followed by statin treatment for positive responders) and unconditional (statin treatment for all).
• The analysis considered national-level costs and atherosclerotic events.
• Key outcomes included total healthcare costs and the number of prevented atherosclerotic events.

Main Results:

• The unconditional treatment strategy was found to be dominant.
• This strategy costs 24% less, equating to $3.2 billion in annual savings.
• It also prevents 25% more atherosclerotic events, approximately 16,800 annually.

Conclusions:

• Routine myocardial perfusion scintigraphy screening for asymptomatic diabetic patients is not a cost-effective strategy.
• Unconditional statin treatment for all asymptomatic diabetic patients is the preferred approach, offering superior economic and clinical benefits.
• Healthcare providers should consider unconditional statin therapy over routine screening to optimize resource allocation and patient outcomes.